<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327846</url>
  </required_header>
  <id_info>
    <org_study_id>CACZ885M2301</org_study_id>
    <secondary_id>2010-022970-14</secondary_id>
    <nct_id>NCT01327846</nct_id>
  </id_info>
  <brief_title>Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)</brief_title>
  <acronym>CANTOS</acronym>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial was to test the
      hypothesis that canakinumab treatment of patients with myocardial infarction (MI) at least
      one month prior to study entry and elevated hsCRP could prevent recurrent cardiovascular
      events.

      The purpose of the extension phase of the main study is to collect additional long-term
      safety data on continued exposure to canakinumab in patients who participated in the pivotal
      phase.

      Sub-study 1 (CACZ885M2301S1): The purpose of this sub-study was to evaluate the effect of
      quarterly subcutaneous canakinumab treatment for 24 months comparted with placebo on the
      carotid plaque burden measured by integrated vascular MRI in patients enrolled in the
      CACZ885M2301 study (CANTOS).

      Sub-study 2 (CACZ885M2301S2): The purpose of this CANTOS sub-study was to determine whether,
      in patients with type 2 diabetes participating in the CANTOS main study, canakinumab compared
      to placebo, on top of standard of care could increase insulin secretion and insulin
      sensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sub-study 1 and 2 were terminated prior to data collection from subjects. However, there is
      an ongoing extension trial where patients are receiving open-drug label.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 11, 2011</start_date>
  <completion_date type="Actual">April 14, 2019</completion_date>
  <primary_completion_date type="Actual">March 28, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of Core Phase First CEC Confirmed Major Adverse Cardiovascular Events (MACE) and Its Components</measure>
    <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
    <description>Time to occurrence of CEC (Cardiovascular clinical events adjudication committee) confirmed MACE, which was a composite endpoint consisting of CEC confirmed CV death, CEC confirmed non-fatal MI,or CEC confirmed non-fatal stroke. Patients with the CEC adjudicated reason for death of &quot;Unknown&quot; were counted as CV (cardiovascular) death.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Substudy 1 (Core Phase): Change From Baseline in Carotid Plaque Burden in the Bifurcation Region of the Index Carotid Artery</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Substudy 2 (Core Phase): Change From Baseline of the Insulin Secretion Rate (ISR) Relative to Glucose 0-30 Min Defined as Î¦30 = AUCISR 0-30 / AUCGluc 0-30 Averaged Across the Year 3, 4, 5 Visits</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients With Core Phase CEC Confirmed CV Death, Non-fatal MI, Non-fatal Stroke, or Hospitalization for Unstable Angina Requiring Unplanned Revascularization</measure>
    <time_frame>From randomization, to end of treatment pus 30 days, up to approximately 6 years</time_frame>
    <description>Occurrence of the composite cardiovascular endpoint consisting of cardiovascular death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina requiring unplanned revascularization.
MACE includes CV death, non-fatal MI and non-fatal stroke. CEC = Clinical Endpoints Committee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients With Core Phase New Onset Type 2 Diabetes Among Patients With Pre-diabetes at Randomization</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
    <description>Time to CEC confirmed new onset of type 2 diabetes among those with pre-diabetes at randomization (i.e. excluding those that are normoglycemic at baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Core Phase All-cause Mortality, Non-fatal MI, or Non-fatal Stroke</measure>
    <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
    <description>Occurrence of the composite endpoint consisting of all-cause mortality, non-fatal IM, or non-fatal stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Core Phase All-cause Mortality</measure>
    <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
    <description>Number of participant deaths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of Adverse Events (Core Phase)</measure>
    <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
    <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the double-blind Core phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of Adverse Events (Extension Phase)</measure>
    <time_frame>From start of Extension phase, to end of treatment plus 30 days, up to approximately 2 years</time_frame>
    <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the Extension phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 1 (Core Phase): Change From Baseline of the Total Vessel Wall Area at Month 3 in the Bifurcation Region of the Index Carotid Artery</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 1 (Core Phase): Mean Total Vessel Wall Area Across the Left and Right Carotid Artery at Month 3 and Month 24</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 1 (Core Phase): Change From Baseline in Corresponding Total Vessel Wall Area in the Left and Right Carotid Arteries</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 1 (Core Phase): The Existence of a Baseline Total Vessel Wall Area by Treatment Interaction as Well as the Consistency of the Treatment Effect Across Subgroups</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 2 (Core Phase): Change From Baseline in Insulin Sensitivity Index</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under Curve (AUC) 0-120 Min of Glucose Concentration, Insulin Concentration, Pro-insulin Concentration, and Insulin Concentration/Glucose Concentration Ratio</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 2 (Core Phase): Change From Baseline in Fasting Pro-Insulin Concentration/Insulin Concentration Ratio</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under the Curve (AUC) 0-120 Min of C-peptide Concentration</measure>
    <time_frame>From randomization up to approximately 6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10066</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Canakinumab Dose 50 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pivotal Phase:
Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care therapy.
Extension Phase:
Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Canakinumab Dose 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pivotal Phase:
Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Canakinumab Dose 300 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pivotal Phase:
Blinded Canakinumab 300 mg quarterly subcutaneous (with one additional dose at week 2) + standard of care therapy.
Extension phase:
Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pivotal Phase:
Blinded matching placebo quarterly subcutaneous + standard of care therapy.
Extension Phase:
Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canakinumab</intervention_name>
    <arm_group_label>Canakinumab Dose 150 mg</arm_group_label>
    <arm_group_label>Canakinumab Dose 300 mg</arm_group_label>
    <arm_group_label>Canakinumab Dose 50 mg</arm_group_label>
    <other_name>ACZ885</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard of care post-MI background therapy includes, but is not limited to, lipid lowering, anti-hypertensive, beta blockers, and anti-platelet therapy as appropriate</description>
    <arm_group_label>Canakinumab Dose 150 mg</arm_group_label>
    <arm_group_label>Canakinumab Dose 300 mg</arm_group_label>
    <arm_group_label>Canakinumab Dose 50 mg</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Study Inclusion Criteria:

          -  Written informed consent

          -  Male, or Female of non-child-bearing potential

          -  Age â¥ 18 years.

          -  Spontaneous MI at least 30 days before randomization. hsCRP â¥ 2 mg/L

        Substudy 1 Inclusion:

          -  All Inclusion from Main Study

          -  Acquisition of evaluable baseline MRI images of bilateral carotid arteries by the
             imaging core laboratory

        Substudy 2 Inclusion:

          -  All inclusion from Main Study

          -  T2D at baseline per Main protocol criteria and be on a stable anti-hyperglycemic
             medication for at least 4 weeks prior to the baseline OGTT test

          -  Willing to have the OGTT assessment started before 10 am

        Main Study Exclusion Criteria:

          -  Pregnant or nursing (lactating) women

          -  Women of child-bearing potential

          -  Any of the following concomitant diseases

          -  Planned coronary revascularization (PCI or CABG)

          -  Major non-cardiac surgical or endoscopic procedure within past 6 months

          -  Multi-vessel CABG surgery within the past 3 years

          -  Symptomatic patients with Class IV heart failure (HF) (New York Heart Association
             [NYHA].

          -  Uncontrolled hypertension

          -  Uncontrolled diabetes

          -  History or evidence of active tuberculosis (TB) infection Substudy 1 Exclusion

          -  All Main exclusion

          -  Patients with prior history of carotid angioplasty, stenting, or carotid atherectomy

          -  Patients with contraindications to MRI examination (brain aneurysm clip, implanted
             neural stimulator, implanted cardiac pacemaker, pacemaker wires or defibrillator,
             prosthetic heart valves, cochlear implant, ocular foreign body or other implanted
             body, tattoos, implanted insulin pump, metal shrapnel or bullet)

          -  Patients prone to claustrophobia or known anxiety disorders

          -  BMI &gt; 40 kg/m2 Substudy 2 Exclusion

          -  This sub-study does not have any additional exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <state>Alabama</state>
        <zip>35611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35235-3424</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-2041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fairhope</city>
        <state>Alabama</state>
        <zip>36532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36617-2293</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92835</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92647</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Orangevale</city>
        <state>California</state>
        <zip>95662</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pomona</city>
        <state>California</state>
        <zip>91767</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143-0792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Visalia</city>
        <state>California</state>
        <zip>93291</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204-4507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <zip>06360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coral Springs</city>
        <state>Florida</state>
        <zip>33065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Davie</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>DeFuniak Springs</city>
        <state>Florida</state>
        <zip>32435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville Beach</city>
        <state>Florida</state>
        <zip>32050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209-6511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32223</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pinellas Park</city>
        <state>Florida</state>
        <zip>33781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33624</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Covington</city>
        <state>Georgia</state>
        <zip>30014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Duluth</city>
        <state>Georgia</state>
        <zip>30096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thomasville</city>
        <state>Georgia</state>
        <zip>31792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coeur d'Alene</city>
        <state>Idaho</state>
        <zip>83814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jerseyville</city>
        <state>Illinois</state>
        <zip>62052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lombard</city>
        <state>Illinois</state>
        <zip>60148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <zip>60160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <zip>50702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madisonville</city>
        <state>Kentucky</state>
        <zip>42431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mandeville</city>
        <state>Louisiana</state>
        <zip>70471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Minden</city>
        <state>Louisiana</state>
        <zip>71055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Opelousas</city>
        <state>Louisiana</state>
        <zip>70570</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Slidell</city>
        <state>Louisiana</state>
        <zip>70458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winnsboro</city>
        <state>Louisiana</state>
        <zip>71295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zachary</city>
        <state>Louisiana</state>
        <zip>70791</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beltsville</city>
        <state>Maryland</state>
        <zip>20705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelsea</city>
        <state>Michigan</state>
        <zip>48118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <zip>48640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <zip>49770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wyoming</city>
        <state>Michigan</state>
        <zip>49519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fridley</city>
        <state>Minnesota</state>
        <zip>55432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Robbinsdale</city>
        <state>Minnesota</state>
        <zip>55422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Picayune</city>
        <state>Mississippi</state>
        <zip>39466</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nashua</city>
        <state>New Hampshire</state>
        <zip>03060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Freehold</city>
        <state>New Jersey</state>
        <zip>07728</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lodi</city>
        <state>New Jersey</state>
        <zip>07644</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ocean City</city>
        <state>New Jersey</state>
        <zip>07712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pomona</city>
        <state>New Jersey</state>
        <zip>08240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Westwood</city>
        <state>New Jersey</state>
        <zip>07675</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Binghamton</city>
        <state>New York</state>
        <zip>13901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kew Gardens</city>
        <state>New York</state>
        <zip>11415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Asheboro</city>
        <state>North Carolina</state>
        <zip>27204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mooresville</city>
        <state>North Carolina</state>
        <zip>28117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sanford</city>
        <state>North Carolina</state>
        <zip>27330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45245</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109-1998</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bartlesville</city>
        <state>Oklahoma</state>
        <zip>74006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bridgeville</city>
        <state>Pennsylvania</state>
        <zip>15017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pottstown</city>
        <state>Pennsylvania</state>
        <zip>19464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cumberland</city>
        <state>Rhode Island</state>
        <zip>02864-1410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fort Mill</city>
        <state>South Carolina</state>
        <zip>29707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moncks Corner</city>
        <state>South Carolina</state>
        <zip>29461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>North Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29582</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Varnville</city>
        <state>South Carolina</state>
        <zip>29944</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greenville</city>
        <state>Tennessee</state>
        <zip>37745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37917</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Allen</city>
        <state>Texas</state>
        <zip>75002-3688</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <zip>77701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <zip>77702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bedford</city>
        <state>Texas</state>
        <zip>76021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brownsville</city>
        <state>Texas</state>
        <zip>78520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gonzales</city>
        <state>Texas</state>
        <zip>78629</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Greenville</city>
        <state>Texas</state>
        <zip>75401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lake Jackson</city>
        <state>Texas</state>
        <zip>77566</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leander</city>
        <state>Texas</state>
        <zip>78641</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Livingston</city>
        <state>Texas</state>
        <zip>77351</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lufkin</city>
        <state>Texas</state>
        <zip>75904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marshall</city>
        <state>Texas</state>
        <zip>75670</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-4801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78238-7676</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bountiful</city>
        <state>Utah</state>
        <zip>84010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Layton</city>
        <state>Utah</state>
        <zip>84041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hopewell</city>
        <state>Virginia</state>
        <zip>23860</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Port Orchard</city>
        <state>Washington</state>
        <zip>98366</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>BahÃ­a Blanca</city>
        <state>Buenos Aires</state>
        <zip>B8000AAT</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1056ABJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1221ADC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1425AGC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1425BWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1440AAD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>7600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>B7600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>B1878DVB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>B1878GEG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ramos Mejia</city>
        <state>Buenos Aires</state>
        <zip>B1704ETD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Isidro</city>
        <state>Buenos Aires</state>
        <zip>B1642DCD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Nicolas</city>
        <state>Buenos Aires</state>
        <zip>B2900DMH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zarate</city>
        <state>Buenos Aires</state>
        <zip>2800</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Capital Federal</state>
        <zip>C1179AAB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Capital Federal</state>
        <zip>C1430CKE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Salvador de Jujuy</city>
        <state>Jujuy</state>
        <zip>Y4600ABF</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Posadas</city>
        <state>Misiones</state>
        <zip>N3300AHX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cipolletti</city>
        <state>Rio Negro</state>
        <zip>8324</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tucuman</city>
        <state>San Miguel De Tucuman</state>
        <zip>T4000ICL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000CXP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000DSV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>T4000EBR</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>T4000IFL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>T4000IIH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <zip>C1119ACN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000AAJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000AAW</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000AAX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000EPU</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000JJS</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5003DCE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5003DCP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5006CBI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5009BSN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5022CPU</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5220XAO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400CBI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400CLH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3410AVV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Formosa</city>
        <zip>P3600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Formosa</city>
        <zip>P3634XAR</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salta</city>
        <zip>4400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Luis</city>
        <zip>D5702JRS</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Fe</city>
        <zip>S3000EOZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Fe</city>
        <zip>S3000EPV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Fe</city>
        <zip>S3000FWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santiago del Estero</city>
        <zip>G4200AQK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tucuman</city>
        <zip>T4000HXU</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Garran</city>
        <state>Australian Capital Territory</state>
        <zip>2606</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <zip>2250</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kogarah</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milton</city>
        <state>Queensland</state>
        <zip>4064</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bundoora</city>
        <state>Victoria</state>
        <zip>3083</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bateman</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Joondalup</city>
        <state>Western Australia</state>
        <zip>6027</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Graz</city>
        <zip>A-8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Linz</city>
        <zip>A-4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Stefan</city>
        <zip>8511</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salzburg</city>
        <zip>A-5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wien</city>
        <zip>A 1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bonheiden</city>
        <zip>2820</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasschaat</city>
        <zip>2930</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brussel</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>De Pinte</city>
        <zip>9840</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huy</city>
        <zip>4500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mechelen</city>
        <zip>2800</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ottignies</city>
        <zip>1340</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tienen</city>
        <zip>3300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <zip>40050-410</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <zip>40140-110</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fortaleza</city>
        <state>CE</state>
        <zip>60430 370</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasilia</city>
        <state>DF</state>
        <zip>70390-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasilia</city>
        <state>DF</state>
        <zip>70658-700</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goiania</city>
        <state>GO</state>
        <zip>74223-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goiania</city>
        <state>GO</state>
        <zip>74605-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30130-060</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uberlandia</city>
        <state>MG</state>
        <zip>38405-320</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uberlandia</city>
        <state>Minas Gerais</state>
        <zip>38411 186</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campo Grande</city>
        <state>MS</state>
        <zip>79080-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Belem</city>
        <state>PA</state>
        <zip>66087-660</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <zip>52051-380</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Curitiba</city>
        <state>PR</state>
        <zip>80730-150</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90610-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Passo Fundo</city>
        <state>RS</state>
        <zip>99010-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pelotas</city>
        <state>RS</state>
        <zip>96015-290</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90560-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90620 001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90880-480</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>91350 200</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Blumenau</city>
        <state>SC</state>
        <zip>89020 430</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13010-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13020-431</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13060 080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santo Andre</city>
        <state>SP</state>
        <zip>09190-615</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sao Jose do Rio Preto</city>
        <state>SP</state>
        <zip>15090 000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>01323 000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>SP</state>
        <zip>05508-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>TatuÃ­</city>
        <state>SP</state>
        <zip>18270-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Votuporanga</city>
        <state>SP</state>
        <zip>15500 003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pazardzhik</city>
        <zip>4400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1202</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1527</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3V 0C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2V 4W3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mount Pearl</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1N 1W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9V 4B4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2M 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5K 2L3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 2P7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 8C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <zip>K9J 0B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1P 2V5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1N9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9W 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Drummondville</city>
        <state>Quebec</state>
        <zip>J2B 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <zip>J8Y 6S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Granby</city>
        <state>Quebec</state>
        <zip>J2G 1T7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Joliette</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lachine</city>
        <state>Quebec</state>
        <zip>H8S 2E4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7M 3L9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Levis</city>
        <state>Quebec</state>
        <zip>G6V 4Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <zip>J4M 2X1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sainte Foy</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1G-2E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St-Jean-sur-Richelieu</city>
        <state>Quebec</state>
        <zip>J3A 1J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ste-Foy</city>
        <state>Quebec</state>
        <zip>G1W 4R4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Terrebonne</city>
        <state>Quebec</state>
        <zip>J6V 2H2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thetford Mines</city>
        <state>Quebec</state>
        <zip>G6G 2V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7H 5M3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1G 3Y8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quebec</city>
        <zip>G3K 2P8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guang Zhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>51000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <zip>014040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai City</city>
        <state>Shanghai</state>
        <zip>200120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Xian</city>
        <state>Shanxi</state>
        <zip>710004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Xian</city>
        <state>Shanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300121</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100028</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100176</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tianjin</city>
        <zip>300142</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tianjin</city>
        <zip>30045</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cartagena</city>
        <state>Bolivar</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manizales</city>
        <state>Caldas</state>
        <zip>1700</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucaramanga</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Floridablanca</city>
        <state>Santander</state>
        <zip>57-7</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Armenia</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barranquilla</city>
        <zip>080020</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>BogotÃ¡</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cartegena</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Florida Blanca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Varazdin</city>
        <state>HRV</state>
        <zip>42000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cakovec</city>
        <zip>40000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Koprivnica</city>
        <zip>48000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krapinske toplice</city>
        <zip>49 217</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krapinske Toplice</city>
        <zip>49217</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Opatija</city>
        <zip>51410</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rijeka</city>
        <zip>51000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Virovitica</city>
        <zip>33000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brandys nad Labem</city>
        <state>Czech Republic</state>
        <zip>250 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jablonec nad Nisou</city>
        <state>Czech Republic</state>
        <zip>466 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kladno</city>
        <state>Czech Republic</state>
        <zip>272 80</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liberec</city>
        <state>Czech Republic</state>
        <zip>460 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Louny</city>
        <state>Czech Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ostrava</city>
        <state>Czech Republic</state>
        <zip>70200</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Plzen</city>
        <state>Czech Republic</state>
        <zip>301 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 11</city>
        <state>Czech Republic</state>
        <zip>148 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 9</city>
        <state>Czech Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roznov pod Radhostem</city>
        <state>Czech Republic</state>
        <zip>756 61</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Semily</city>
        <state>Czech Republic</state>
        <zip>513 31</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Svitavy</city>
        <state>Czech Republic</state>
        <zip>568 25</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trebic</city>
        <state>Czech Republic</state>
        <zip>674 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Usti nad Labem</city>
        <state>Czech Republic</state>
        <zip>400 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Usti nad Orlici</city>
        <state>Czech Republic</state>
        <zip>562 18</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vyskov</city>
        <state>Czech Republic</state>
        <zip>68001</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Znojmo</city>
        <state>Czech Republic</state>
        <zip>66902</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Most</city>
        <state>CZE</state>
        <zip>434 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 2</city>
        <state>CZE</state>
        <zip>128 08</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trutnov</city>
        <state>CZE</state>
        <zip>46063</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Benesov</city>
        <zip>25601</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brno Bohunice</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Broumov</city>
        <zip>550 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kolin</city>
        <zip>280 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marianske lazne</city>
        <zip>353 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pardubice</city>
        <zip>530 02</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Prague 4 - Krc</city>
        <zip>14059</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha</city>
        <zip>12808</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Slany</city>
        <zip>274 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Teplice</city>
        <zip>415 29</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uherske Hradiste</city>
        <zip>68601</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Parnu</city>
        <zip>80010</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saku</city>
        <zip>75501</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>10611</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>13619</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tartu</city>
        <zip>50410</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Viljandi County</city>
        <zip>71024</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>VÃµru</city>
        <zip>65608</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muehlheim An Der Ruhr</city>
        <state>NRW</state>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Balve</city>
        <zip>58802</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10367</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>13055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bochum</city>
        <zip>44787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Borna</city>
        <zip>04552</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chemnitz</city>
        <zip>09122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chemnitz</city>
        <zip>09130</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dillingen</city>
        <zip>66763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dinslaken</city>
        <zip>46535</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01309</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Duisburg</city>
        <zip>47137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40597</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ebersbach</city>
        <zip>02730</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Elsterwerda</city>
        <zip>04910</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Falkensee</city>
        <zip>14612</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Frankfurt</city>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Frankfurt</city>
        <zip>60594</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fulda</city>
        <zip>36037</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Giengen</city>
        <zip>89537</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goerlitz</city>
        <zip>02826</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haag</city>
        <zip>83527</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Halle Saale</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22041</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22393</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22765</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heilbronn</city>
        <zip>74078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huy / OT Anderbeck</city>
        <zip>38836</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jerichow</city>
        <zip>39319</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kallstadt</city>
        <zip>67169</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kamp-Lintfort</city>
        <zip>47475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kassel</city>
        <zip>34127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kiel</city>
        <zip>24119</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Koeln</city>
        <zip>51065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kuenzing</city>
        <zip>94550</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leipzig</city>
        <zip>04107</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>LÃ¼neburg</city>
        <zip>21339</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Magdeburg</city>
        <zip>39112</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mainz</city>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mayen</city>
        <zip>56727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Meissen</city>
        <zip>01662</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>MeiÃen</city>
        <zip>01662</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muehldorf Am Inn</city>
        <zip>84453</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muehlhausen</city>
        <zip>99974</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Neuhofen</city>
        <zip>67141</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Neunkirchen</city>
        <zip>66539</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Northeim</city>
        <zip>37154</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nurnberg</city>
        <zip>90402</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oelde</city>
        <zip>59302</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oschatz</city>
        <zip>04758</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Paderborn</city>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Potsdam</city>
        <zip>14469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rednitzhembach</city>
        <zip>91126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Reinfeld</city>
        <zip>23858</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rostock</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>RÃ¼dersdorf</city>
        <zip>15562</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wolmirstedt</city>
        <zip>39326</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <state>GR</state>
        <zip>14233</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Magoula</city>
        <state>GR</state>
        <zip>190 18</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thessaloniki</city>
        <state>GR</state>
        <zip>564 03</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thessaloniki</city>
        <state>GR</state>
        <zip>570 10</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Voula</city>
        <state>GR</state>
        <zip>166 73</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>106 76</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>115 27</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chalkida</city>
        <zip>GR 341 00</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Crete Heraklion</city>
        <zip>714 09</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heraklion Crete</city>
        <zip>711 10</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Patras</city>
        <zip>265 00</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guatemala City</city>
        <zip>01001</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guatemala City</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guatemala City</city>
        <zip>01011</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guatemala City</city>
        <zip>01015</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zalaegerszeg</city>
        <state>Zala</state>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1042</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1125</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>1145</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Budapest</city>
        <zip>H-1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Csongrad</city>
        <zip>6640</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Komarom</city>
        <zip>2921</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miskolc</city>
        <zip>3530</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mosonmagyarovar</city>
        <zip>9200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>NyiregyhÃ¡za</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pecs</city>
        <zip>7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Szeged</city>
        <zip>H 6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Szekesfehervar</city>
        <zip>H-8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Szentes</city>
        <zip>6600</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kopavogur</city>
        <zip>201</zip>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Reykjavik</city>
        <zip>IS-101</zip>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Reykjavik</city>
        <zip>IS-109</zip>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nampally</city>
        <state>Andhra Pradesh</state>
        <zip>500 001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nellore</city>
        <state>Andhra Pradesh</state>
        <zip>524 003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tirupati</city>
        <state>Andhra Pradesh</state>
        <zip>517 5-7</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vijayawada</city>
        <state>Andhra Pradesh</state>
        <zip>520 008</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vijayawada</city>
        <state>Andhra Pradesh</state>
        <zip>520010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vishakhapatnam</city>
        <state>Andhra Pradesh</state>
        <zip>530 013</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guntur</city>
        <state>Andhrapradesh</state>
        <zip>522001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380 051</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380006</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>382428</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Surat</city>
        <state>Gujarat</state>
        <zip>395 002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Surat</city>
        <state>Gujarat</state>
        <zip>395001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vadodara</city>
        <state>Gujarat</state>
        <zip>390015</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560 055</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bengaluru</city>
        <state>Karnataka</state>
        <zip>560034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manipal</city>
        <state>Karnataka</state>
        <zip>576104</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kochi</city>
        <state>Kerala</state>
        <zip>682 018</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>440 010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>44000033</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>440012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nashik</city>
        <state>Maharashtra</state>
        <zip>422 005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ludhiana</city>
        <state>Punjab</state>
        <zip>141002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ludhiana</city>
        <state>Punjab</state>
        <zip>141012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ludhiana</city>
        <state>Punjab</state>
        <zip>141421</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mohali</city>
        <state>Punjab</state>
        <zip>160 062</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bikaner</city>
        <state>Rajasthan</state>
        <zip>334003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302016</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302024</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600081</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamil Nadu</state>
        <zip>641037</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madurai</city>
        <state>Tamil NADU</state>
        <zip>625107</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamilnadu</state>
        <zip>641 018</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>500 063</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Secunderabad</city>
        <state>Telangana</state>
        <zip>500003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ghaziabad</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Varanasi</city>
        <state>Uttar Pradesh</state>
        <zip>224105</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <zip>380025</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rajasthan</city>
        <zip>324005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ancona</city>
        <state>AN</state>
        <zip>60128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fermo</city>
        <state>AP</state>
        <zip>63023</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cortona</city>
        <state>AR</state>
        <zip>52044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Treviglio</city>
        <state>BG</state>
        <zip>24047</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montichiari</city>
        <state>BS</state>
        <zip>25018</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Monserrato</city>
        <state>CA</state>
        <zip>09042</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Maria Capua Vetere</city>
        <state>CE</state>
        <zip>81055</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chieti</city>
        <state>CH</state>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cona</city>
        <state>FE</state>
        <zip>44100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Foggia</city>
        <state>FG</state>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pozzilli</city>
        <state>IS</state>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20145</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rozzano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Massa</city>
        <state>MS</state>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Piacenza</city>
        <state>PC</state>
        <zip>29100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Parma</city>
        <state>PR</state>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Casorate Primo</city>
        <state>PV</state>
        <zip>27022</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sassari</city>
        <state>SS</state>
        <zip>07100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Palmanova</city>
        <state>UD</state>
        <zip>33057</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Daniele Del Friuli</city>
        <state>UD</state>
        <zip>33038</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Verona</city>
        <state>VR</state>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Soriano Calabro</city>
        <state>VV</state>
        <zip>89831</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Veruno</city>
        <zip>28010</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ichinomiya</city>
        <state>Aichi</state>
        <zip>491-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>453-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seto-city</city>
        <state>Aichi</state>
        <zip>489-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Funabashi</city>
        <state>Chiba</state>
        <zip>273-8588</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Matsudo city</city>
        <state>Chiba</state>
        <zip>271 0077</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Matsudo-city</city>
        <state>Chiba</state>
        <zip>270-2251</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kasuga</city>
        <state>Fukuoka</state>
        <zip>816-0864</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kurume-city</city>
        <state>Fukuoka</state>
        <zip>830-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Onga-gun</city>
        <state>Fukuoka</state>
        <zip>807-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yukuhashi</city>
        <state>Fukuoka</state>
        <zip>824-0026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ogaki-city</city>
        <state>Gifu</state>
        <zip>503-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fujioka city</city>
        <state>Gunma</state>
        <zip>375-8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Takasaki-city</city>
        <state>Gunma</state>
        <zip>370-0036</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hatsukaichi city</city>
        <state>Hiroshima</state>
        <zip>738 8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amagasaki city</city>
        <state>Hyogo</state>
        <zip>660 8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amagasaki-city</city>
        <state>Hyogo</state>
        <zip>661-0976</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nishinomiya</city>
        <state>Hyogo</state>
        <zip>663 8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Takarazuka-city</city>
        <state>Hyogo</state>
        <zip>665-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Higashiibaraki-gun</city>
        <state>Ibaraki</state>
        <zip>311-3193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hitachi-city</city>
        <state>Ibaraki</state>
        <zip>317-0077</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sakaide-city</city>
        <state>Kagawa</state>
        <zip>762-0007</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Takamatsu city</city>
        <state>Kagawa</state>
        <zip>760 8557</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>234-0054</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kumamoto City</city>
        <state>Kumamoto</state>
        <zip>860-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kyoto-city</city>
        <state>Kyoto</state>
        <zip>607-8062</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sendai city</city>
        <state>Miyagi</state>
        <zip>980 8574</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sendai-shi</city>
        <state>Miyagi</state>
        <zip>983 8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagano City</city>
        <state>Nagano</state>
        <zip>380 0814</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hirakata-City</city>
        <state>Osaka</state>
        <zip>573-0153</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Osaka-city</city>
        <state>Osaka</state>
        <zip>543-0035</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Osaka-city</city>
        <state>Osaka</state>
        <zip>543-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Osaka-city</city>
        <state>Osaka</state>
        <zip>558-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Takatsuki</city>
        <state>Osaka</state>
        <zip>569-0852</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sayama-city</city>
        <state>Saitama</state>
        <zip>350-1305</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tokorozawa</city>
        <state>Saitama</state>
        <zip>359-1142</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kusatsu-city</city>
        <state>Shiga</state>
        <zip>525-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Komatsushima-city</city>
        <state>Tokushima</state>
        <zip>773-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8603</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chiyoda-ku</city>
        <state>Tokyo</state>
        <zip>101-8309</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chiyoda-ku</city>
        <state>Tokyo</state>
        <zip>101-8643</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fuchu-city</city>
        <state>Tokyo</state>
        <zip>183-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Itabashi-ku</city>
        <state>Tokyo</state>
        <zip>173-8610</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon-Do</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>443380</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uijeongbu-Si</city>
        <state>Gyeonggi-do</state>
        <zip>480-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daejeon</city>
        <state>Korea</state>
        <zip>35015</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Seocho Gu</state>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Busan</city>
        <zip>602739</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daegu</city>
        <zip>705 718</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daegu</city>
        <zip>705703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gwangju</city>
        <zip>61469</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liepaja</city>
        <state>LV</state>
        <zip>LV-3414</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riga</city>
        <state>LV</state>
        <zip>LV-1005</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ventspils</city>
        <state>LV</state>
        <zip>LV-3601</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riga</city>
        <zip>1012</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Valmiera</city>
        <zip>4201</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <state>LTU</state>
        <zip>LT 50161</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Klaipeda</city>
        <state>LTU</state>
        <zip>LT-92288</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alytus</city>
        <zip>LT-62386</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-44320</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-49387</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-49449</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kedainiai</city>
        <zip>LT-57164</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Panevezys</city>
        <zip>LT-37460</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Siauliai</city>
        <zip>LT-76231</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vilnius</city>
        <zip>LT-08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44210</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44280</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Luis Potosi</city>
        <state>San Luis PotosÃ­</state>
        <zip>78240</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <zip>80230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Queretaro</city>
        <zip>76000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Maastricht</city>
        <state>AZ</state>
        <zip>5800</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Apeldoorn</city>
        <state>DZ</state>
        <zip>7334</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sneek</city>
        <state>The Netherlands</state>
        <zip>8601 ZR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amersfoort</city>
        <zip>3813 TZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amstelveen</city>
        <zip>1186 AM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Breda</city>
        <zip>4811SW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Deventer</city>
        <zip>7416 SE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Doetinchem</city>
        <zip>7009 BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ede</city>
        <zip>6716 RP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gouda</city>
        <zip>2803 HH</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Groningen</city>
        <zip>NL-9711 SG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heerlen</city>
        <zip>6419 PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hoorn</city>
        <zip>1624 NP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8934 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Meppel</city>
        <zip>7943 KA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rotterdam</city>
        <zip>3001 HG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rotterdam</city>
        <zip>3083 AN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tiel</city>
        <zip>4002 WP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Venlo</city>
        <zip>5912 BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alesund</city>
        <zip>NO-6026</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Elverum</city>
        <zip>2408</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamar</city>
        <zip>2317</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Harstad</city>
        <zip>9481</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>HÃ¸nefoss</city>
        <zip>3501</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lillehammer</city>
        <zip>2629</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moss</city>
        <zip>1523</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nesttun</city>
        <zip>5221</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oslo</city>
        <zip>0303</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sandefjord</city>
        <zip>3211</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Skedsmokorset</city>
        <zip>2020</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stavanger</city>
        <zip>4068</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tonsberg</city>
        <zip>3116</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trondheim</city>
        <zip>7011</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tynset</city>
        <zip>2501</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bellavista</city>
        <state>Lima</state>
        <zip>CALLAO 02</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Isidro</city>
        <state>Lima</state>
        <zip>27</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Martin de Porres</city>
        <state>Lima</state>
        <zip>31</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lima</city>
        <zip>LIMA 39</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-435</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-157</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-302</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-423</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lublin</city>
        <zip>20-538</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Olawa</city>
        <zip>55-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ostrow Wielkopolski</city>
        <zip>63-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-375</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Poznan</city>
        <zip>61-874</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pulawy</city>
        <zip>24100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rumia</city>
        <zip>84-230</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Skierniewice</city>
        <zip>96-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Warszawa</city>
        <zip>04-073</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wegrow</city>
        <zip>07-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wloclawek</city>
        <zip>87-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manati</city>
        <zip>00674</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mayaguez</city>
        <zip>00680</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ponce</city>
        <zip>00716</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ponce</city>
        <zip>00717</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Juan</city>
        <zip>00909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Juan</city>
        <zip>00926</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Juan</city>
        <zip>00936-6528</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pitesti</city>
        <state>Arges</state>
        <zip>110438</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <state>District 1</state>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucuresti</city>
        <state>District 1</state>
        <zip>010225</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <state>District 2</state>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucuresti</city>
        <state>District 4</state>
        <zip>4204179</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oradea</city>
        <state>Jud Bihor</state>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cluj Napoca</city>
        <state>Jud Cluj</state>
        <zip>400015</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iasi</city>
        <state>Jud Iasi</state>
        <zip>700732</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <state>Jud Mures</state>
        <zip>540043</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Constanta</city>
        <state>Jud. Constanta</state>
        <zip>900591</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Craiova</city>
        <state>Jud. Dolj</state>
        <zip>200497</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iasi</city>
        <state>Jud. Iasi</state>
        <zip>700111</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <state>Mures</state>
        <zip>540124</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tg Mures</city>
        <state>Mures</state>
        <zip>540136</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Braila</city>
        <state>ROM</state>
        <zip>810249</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Timisoara</city>
        <state>Timis</state>
        <zip>300362</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baia Mare</city>
        <zip>430123</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasov</city>
        <zip>500283</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <zip>021659</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>011728</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>011774</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cluj Napoca</city>
        <zip>400006</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400347</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Craiova</city>
        <zip>200642</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oradea</city>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pitesti</city>
        <zip>110084</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sibiu</city>
        <zip>550371</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <zip>540096</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <zip>540142</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu-Mures</city>
        <zip>540136</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300310</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454048</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620102</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620137</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izhevsk</city>
        <zip>426063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kazan</city>
        <zip>420012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650029</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kirov</city>
        <zip>610027</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kirov</city>
        <zip>610035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krasnodar</city>
        <zip>350086</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>117198</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>117556</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>119881</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>125284</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>127018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>127473</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Penza</city>
        <zip>440067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Perm</city>
        <zip>614097</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Perm</city>
        <zip>614107</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Petrozavodsk</city>
        <zip>185019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>195067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>192257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Samara</city>
        <zip>443070</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Samara</city>
        <zip>443096</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saratov</city>
        <zip>410012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sestroretsk</city>
        <zip>197706</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Smolensk</city>
        <zip>214018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>194295</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>196084</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>190013</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St.- Petersburg</city>
        <zip>197110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St.Petersburg</city>
        <zip>193163</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Syktyvkar</city>
        <zip>167981</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tyumen</city>
        <zip>625026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vladimir</city>
        <zip>600020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yekaterinburg</city>
        <zip>620109</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beograd</city>
        <zip>11040</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Niska Banja</city>
        <zip>18205</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <state>Slovak Republic</state>
        <zip>826 06</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brezno</city>
        <state>Slovak Republic</state>
        <zip>977 42</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Komarno</city>
        <state>Slovak Republic</state>
        <zip>94575</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <state>Slovak Republic</state>
        <zip>040 22</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Povazska Bystrica</city>
        <state>Slovak Republic</state>
        <zip>017 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Presov</city>
        <state>Slovak Republic</state>
        <zip>080 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Presov</city>
        <state>Slovak Republic</state>
        <zip>08001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rimavska Sobota</city>
        <state>Slovak Republic</state>
        <zip>97901</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Svidnik</city>
        <state>Slovak Republic</state>
        <zip>08901</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Velky Krtis</city>
        <state>Slovak Republic</state>
        <zip>990 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Banska Bystrica</city>
        <zip>97401</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <zip>81369</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <zip>831 06</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <zip>841 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dubnica nad Vahom</city>
        <zip>01841</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dunajska Streda</city>
        <zip>929 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Galanta</city>
        <zip>92701</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <zip>04001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Levice</city>
        <zip>934 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucenec</city>
        <zip>984 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucenec</city>
        <zip>98403</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Martin</city>
        <zip>036 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nitra</city>
        <zip>949 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nitra</city>
        <zip>94901</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nove Zamky</city>
        <zip>940 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nove Zamky</city>
        <zip>94002</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Presov</city>
        <zip>081 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trnava</city>
        <zip>91702</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zilina</city>
        <zip>012 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Celje</city>
        <zip>3000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Golnik</city>
        <zip>4204</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Durban</city>
        <state>Kwa-Zulu Natal</state>
        <zip>4052</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7405</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alberton</city>
        <zip>1449</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bloemfontein</city>
        <zip>9301</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7405</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Centurion</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Johannesburg</city>
        <zip>2193</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kempton Park</city>
        <zip>1620</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pretoria</city>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Western Cape</city>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>GÃ¶teborg</city>
        <state>Vastra Gotalands Lan</state>
        <zip>SE-413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Boras</city>
        <zip>506 30</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goteborg</city>
        <zip>416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kristianstad</city>
        <zip>291 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>LuleÃ¥</city>
        <zip>972 33</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lund</city>
        <zip>22142</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lund</city>
        <zip>222 21</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>MalmÃ¶</city>
        <zip>214 22</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Molndal</city>
        <zip>431 80</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>SkanÃ¶r</city>
        <zip>239 33</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Skelleftea</city>
        <zip>931 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>SE-111 35</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uddevalla</city>
        <zip>451 50</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vallingby</city>
        <zip>162 68</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vasteras</city>
        <zip>72189</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ãstersund</city>
        <zip>831 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taichung</city>
        <state>Taiwan ROC</state>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <state>Taiwan, ROC</state>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Changhua</city>
        <zip>50006</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaohsiung City</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaohsiung</city>
        <zip>80756</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taichung</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tainan</city>
        <zip>71004</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <zip>10449</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <zip>114</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taoyuan</city>
        <zip>33305</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yilan</city>
        <zip>26058</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Eskisehir</city>
        <state>Meselik</state>
        <zip>26480</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aydin</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34304</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izmir</city>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kocaeli</city>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mersin</city>
        <zip>33079</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sivas</city>
        <zip>58140</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Basingstoke</city>
        <state>Hampshire</state>
        <zip>RG24 9NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newport</city>
        <state>Isle Of Wight</state>
        <zip>PO30 5TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salford</city>
        <state>Manchester</state>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Whitby</city>
        <state>North Yorkshire</state>
        <zip>Y021 1SD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dundee</city>
        <state>Perthshire</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Axbridge</city>
        <state>Somerset</state>
        <zip>BS26 2BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taunton</city>
        <state>Somerset</state>
        <zip>TA1 5DA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF5 4AD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barnet</city>
        <zip>EN5 3DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berkshire</city>
        <zip>RG2 0TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2SQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 5GJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cheshire</city>
        <zip>CW11 1EQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chesterfield</city>
        <zip>S40 4AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chorley</city>
        <zip>PR7 7NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Exeter</city>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0SP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0XA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Irvine</city>
        <zip>KA12 0AY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liverpool</city>
        <zip>L22 0LG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>London</city>
        <zip>EC14 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manchester</city>
        <zip>M15 6SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Newport</city>
        <zip>NP20 2UB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Norwich</city>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wiltshire</city>
        <zip>SN15 2SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Worcester</city>
        <zip>WR5 1DD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>York</city>
        <zip>YO31 8HE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Guatemala</country>
    <country>Hungary</country>
    <country>Iceland</country>
    <country>India</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>Slovenia</country>
    <country>South Africa</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
    <country>Ecuador</country>
    <country>Former Serbia and Montenegro</country>
    <country>Israel</country>
  </removed_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 29, 2011</study_first_submitted>
  <study_first_submitted_qc>March 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2011</study_first_posted>
  <results_first_submitted>November 25, 2019</results_first_submitted>
  <results_first_submitted_qc>January 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 22, 2020</results_first_posted>
  <disposition_first_submitted>February 23, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>February 23, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 26, 2018</disposition_first_posted>
  <last_update_submitted>January 10, 2020</last_update_submitted>
  <last_update_submitted_qc>January 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Death</keyword>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Stroke</keyword>
  <keyword>Canakinumab</keyword>
  <keyword>IL-1B</keyword>
  <keyword>hsCRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 13, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT01327846/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT01327846/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>10066 patients enrolled in the Core phase (4 randomized groups); 5 patients enrolled in the safety set were not included in efficacy set. 5777 patients continued in the Extension phase (539 entered only the washout period, 5238 entered the treatment period(s)). The Core phase completed as planned; âterminatedâ applies to the Extension phase.</recruitment_details>
      <pre_assignment_details>A total of 17482 patients were screened, and 10102 patients completed the screening phase. A total of 6430 patients did not complete the screening phase due to screen failure.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group I</title>
          <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="P2">
          <title>Group II</title>
          <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="P3">
          <title>Group III</title>
          <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="P4">
          <title>Group IV</title>
          <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Core Phase</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2263"/>
                <participants group_id="P2" count="2284"/>
                <participants group_id="P3" count="2170"/>
                <participants group_id="P4" count="3344"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2235"/>
                <participants group_id="P2" count="2252"/>
                <participants group_id="P3" count="2144"/>
                <participants group_id="P4" count="3311"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="33"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Subject decision (vital status: missing)</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject decision (vital stat: unkn)</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject decision (vital stat: dead)</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject decision (vital stat: alive)</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Extension Phase</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1267"/>
                <participants group_id="P2" count="1287"/>
                <participants group_id="P3" count="1279"/>
                <participants group_id="P4" count="1944"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Stopped/Discontinued Study at Washout</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="97"/>
                <participants group_id="P3" count="137"/>
                <participants group_id="P4" count="178"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Treatment Period</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="49"/>
                <participants group_id="P4" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Details Missing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="168"/>
                <participants group_id="P2" count="143"/>
                <participants group_id="P3" count="187"/>
                <participants group_id="P4" count="238"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1099"/>
                <participants group_id="P2" count="1144"/>
                <participants group_id="P3" count="1092"/>
                <participants group_id="P4" count="1706"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study terminated by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="1073"/>
                <participants group_id="P2" count="1124"/>
                <participants group_id="P3" count="1067"/>
                <participants group_id="P4" count="1660"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="19"/>
                <participants group_id="P4" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Technical Problems</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Full analysis set (FAS) â All randomized patients except for those who were misrandomized or from sites with serious GCP violations.
Baseline characteristics data are presented for patients enrolled in the Core phase of the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Group I</title>
          <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="B2">
          <title>Group II</title>
          <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="B3">
          <title>Group III</title>
          <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="B4">
          <title>Group IV</title>
          <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2263"/>
            <count group_id="B2" value="2284"/>
            <count group_id="B3" value="2170"/>
            <count group_id="B4" value="3344"/>
            <count group_id="B5" value="10061"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <population>FAS</population>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 65</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1424"/>
                    <measurement group_id="B2" value="1428"/>
                    <measurement group_id="B3" value="1350"/>
                    <measurement group_id="B4" value="2089"/>
                    <measurement group_id="B5" value="6291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 65</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="839"/>
                    <measurement group_id="B2" value="856"/>
                    <measurement group_id="B3" value="820"/>
                    <measurement group_id="B4" value="1255"/>
                    <measurement group_id="B5" value="3770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>FAS</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="606"/>
                    <measurement group_id="B2" value="575"/>
                    <measurement group_id="B3" value="541"/>
                    <measurement group_id="B4" value="865"/>
                    <measurement group_id="B5" value="2587"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1657"/>
                    <measurement group_id="B2" value="1709"/>
                    <measurement group_id="B3" value="1629"/>
                    <measurement group_id="B4" value="2479"/>
                    <measurement group_id="B5" value="7474"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>FAS</population>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1804"/>
                    <measurement group_id="B2" value="1808"/>
                    <measurement group_id="B3" value="1772"/>
                    <measurement group_id="B4" value="2652"/>
                    <measurement group_id="B5" value="8036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="106"/>
                    <measurement group_id="B5" value="318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="265"/>
                    <measurement group_id="B2" value="278"/>
                    <measurement group_id="B3" value="232"/>
                    <measurement group_id="B4" value="388"/>
                    <measurement group_id="B5" value="1163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="41"/>
                    <measurement group_id="B4" value="82"/>
                    <measurement group_id="B5" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="112"/>
                    <measurement group_id="B5" value="313"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Analysis of Core Phase First CEC Confirmed Major Adverse Cardiovascular Events (MACE) and Its Components</title>
        <description>Time to occurrence of CEC (Cardiovascular clinical events adjudication committee) confirmed MACE, which was a composite endpoint consisting of CEC confirmed CV death, CEC confirmed non-fatal MI,or CEC confirmed non-fatal stroke. Patients with the CEC adjudicated reason for death of &quot;Unknown&quot; were counted as CV (cardiovascular) death.</description>
        <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
        <population>Full Analysis Set (FAS): All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Core Phase First CEC Confirmed Major Adverse Cardiovascular Events (MACE) and Its Components</title>
          <description>Time to occurrence of CEC (Cardiovascular clinical events adjudication committee) confirmed MACE, which was a composite endpoint consisting of CEC confirmed CV death, CEC confirmed non-fatal MI,or CEC confirmed non-fatal stroke. Patients with the CEC adjudicated reason for death of &quot;Unknown&quot; were counted as CV (cardiovascular) death.</description>
          <population>Full Analysis Set (FAS): All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2263"/>
                <count group_id="O2" value="2284"/>
                <count group_id="O3" value="2170"/>
                <count group_id="O4" value="3344"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MACE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="322"/>
                    <measurement group_id="O2" value="320"/>
                    <measurement group_id="O3" value="313"/>
                    <measurement group_id="O4" value="535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CV death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151"/>
                    <measurement group_id="O2" value="144"/>
                    <measurement group_id="O3" value="137"/>
                    <measurement group_id="O4" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MI (fatal and non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174"/>
                    <measurement group_id="O2" value="159"/>
                    <measurement group_id="O3" value="169"/>
                    <measurement group_id="O4" value="292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MI (non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171"/>
                    <measurement group_id="O2" value="158"/>
                    <measurement group_id="O3" value="168"/>
                    <measurement group_id="O4" value="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke (fatal and non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="63"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke (non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="63"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>H11: The hazard rate of first adjudication committee confirmed MACE in the canakinumab 300 mg dose group is greater than or equal to the hazard rate of the placebo group</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.0648</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
            <estimate_desc>MACE</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>H21: The hazard rate of first adjudication committee confirmed MACE in the canakinumab 150 mg dose group is greater than or equal to the hazard rate of the placebo group</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.0241</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>MACE</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>H31: The hazard rate of first adjudication committee confirmed MACE in the canakinumab 50 mg dose group is greater than or equal to the hazard rate of the placebo group.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.1895</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
            <estimate_desc>MACE</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.572</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>1.16</ci_upper_limit>
            <estimate_desc>CV death</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.296</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
            <estimate_desc>CV death</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.369</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>1.12</ci_upper_limit>
            <estimate_desc>CV death</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.067</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.69</ci_lower_limit>
            <ci_upper_limit>1.01</ci_upper_limit>
            <estimate_desc>MI (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.006</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
            <estimate_desc>MI (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.542</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>1.14</ci_upper_limit>
            <estimate_desc>MI (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.68</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
            <estimate_desc>MI (non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
            <estimate_desc>MI (non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>1.14</ci_upper_limit>
            <estimate_desc>MI (non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.190</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.56</ci_lower_limit>
            <ci_upper_limit>1.12</ci_upper_limit>
            <estimate_desc>Stroke (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.912</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>1.35</ci_upper_limit>
            <estimate_desc>Stroke (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.871</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>1.43</ci_upper_limit>
            <estimate_desc>Stroke (fatal and non-fatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
            <estimate_desc>Stroke (nonfatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>1.37</ci_upper_limit>
            <estimate_desc>Stroke (nonfatal)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>1.45</ci_upper_limit>
            <estimate_desc>Stroke (nonfatal)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Substudy 1 (Core Phase): Change From Baseline in Carotid Plaque Burden in the Bifurcation Region of the Index Carotid Artery</title>
        <time_frame>24 months</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 1 (Core Phase): Change From Baseline in Carotid Plaque Burden in the Bifurcation Region of the Index Carotid Artery</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Substudy 2 (Core Phase): Change From Baseline of the Insulin Secretion Rate (ISR) Relative to Glucose 0-30 Min Defined as Î¦30 = AUCISR 0-30 / AUCGluc 0-30 Averaged Across the Year 3, 4, 5 Visits</title>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 2 (Core Phase): Change From Baseline of the Insulin Secretion Rate (ISR) Relative to Glucose 0-30 Min Defined as Î¦30 = AUCISR 0-30 / AUCGluc 0-30 Averaged Across the Year 3, 4, 5 Visits</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients With Core Phase CEC Confirmed CV Death, Non-fatal MI, Non-fatal Stroke, or Hospitalization for Unstable Angina Requiring Unplanned Revascularization</title>
        <description>Occurrence of the composite cardiovascular endpoint consisting of cardiovascular death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina requiring unplanned revascularization.
MACE includes CV death, non-fatal MI and non-fatal stroke. CEC = Clinical Endpoints Committee</description>
        <time_frame>From randomization, to end of treatment pus 30 days, up to approximately 6 years</time_frame>
        <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Core Phase CEC Confirmed CV Death, Non-fatal MI, Non-fatal Stroke, or Hospitalization for Unstable Angina Requiring Unplanned Revascularization</title>
          <description>Occurrence of the composite cardiovascular endpoint consisting of cardiovascular death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina requiring unplanned revascularization.
MACE includes CV death, non-fatal MI and non-fatal stroke. CEC = Clinical Endpoints Committee</description>
          <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2263"/>
                <count group_id="O2" value="2284"/>
                <count group_id="O3" value="2170"/>
                <count group_id="O4" value="3344"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MACE or unstable angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="348"/>
                    <measurement group_id="O2" value="352"/>
                    <measurement group_id="O3" value="344"/>
                    <measurement group_id="O4" value="601"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unstable angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.0648</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
            <estimate_desc>MACE or unstable angina</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.0241</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.83</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
            <estimate_desc>MACE or unstable angina</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.1895</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.79</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
            <estimate_desc>MACE or unstable angina</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.007</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>0.86</ci_upper_limit>
            <estimate_desc>unstable angina</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.022</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
            <estimate_desc>unstable angina</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.086</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.48</ci_lower_limit>
            <ci_upper_limit>1.05</ci_upper_limit>
            <estimate_desc>unstable angina</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients With Core Phase New Onset Type 2 Diabetes Among Patients With Pre-diabetes at Randomization</title>
        <description>Time to CEC confirmed new onset of type 2 diabetes among those with pre-diabetes at randomization (i.e. excluding those that are normoglycemic at baseline)</description>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Core Phase New Onset Type 2 Diabetes Among Patients With Pre-diabetes at Randomization</title>
          <description>Time to CEC confirmed new onset of type 2 diabetes among those with pre-diabetes at randomization (i.e. excluding those that are normoglycemic at baseline)</description>
          <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1132"/>
                <count group_id="O2" value="1094"/>
                <count group_id="O3" value="1089"/>
                <count group_id="O4" value="1645"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                    <measurement group_id="O2" value="171"/>
                    <measurement group_id="O3" value="161"/>
                    <measurement group_id="O4" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.8456</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.23</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.8456</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.29</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.6541</p_value>
            <p_value_desc>1-sided adjusted for multiplicity using weighted Dunnett test. [significance level 0.0245]</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Core Phase All-cause Mortality, Non-fatal MI, or Non-fatal Stroke</title>
        <description>Occurrence of the composite endpoint consisting of all-cause mortality, non-fatal IM, or non-fatal stroke</description>
        <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
        <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Core Phase All-cause Mortality, Non-fatal MI, or Non-fatal Stroke</title>
          <description>Occurrence of the composite endpoint consisting of all-cause mortality, non-fatal IM, or non-fatal stroke</description>
          <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2263"/>
                <count group_id="O2" value="2284"/>
                <count group_id="O3" value="2170"/>
                <count group_id="O4" value="3344"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="403"/>
                    <measurement group_id="O2" value="395"/>
                    <measurement group_id="O3" value="394"/>
                    <measurement group_id="O4" value="661"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.028</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.87</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
            <estimate_desc>All-cause mortality or MI or Stroke</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.011</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
            <estimate_desc>All-cause mortality or MI or Stroke</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.377</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
            <estimate_desc>All-cause mortality or MI or Stroke</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Core Phase All-cause Mortality</title>
        <description>Number of participant deaths</description>
        <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
        <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Core Phase All-cause Mortality</title>
          <description>Number of participant deaths</description>
          <population>FAS: All randomized patients except for those who were misrandomized or from sites with serious GCP violations</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2263"/>
                <count group_id="O2" value="2284"/>
                <count group_id="O3" value="2170"/>
                <count group_id="O4" value="3344"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="239"/>
                    <measurement group_id="O2" value="238"/>
                    <measurement group_id="O3" value="228"/>
                    <measurement group_id="O4" value="375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.406</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.79</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
            <estimate_desc>All-cause mortality</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.329</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>1.09</ci_upper_limit>
            <estimate_desc>All-cause mortality</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>A HR &lt; 1 favors Canakinumab</non_inferiority_desc>
            <p_value>0.597</p_value>
            <p_value_desc>2-sided unadjusted p-value</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
            <estimate_desc>All-cause mortality</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summary of Adverse Events (Core Phase)</title>
        <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the double-blind Core phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
        <time_frame>From randomization, to end of treatment plus 30 days, up to approximately 6 years</time_frame>
        <population>Safety set: All patients who received at least one dose of study treatment and had at least one post-baseline safety assessment</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Summary of Adverse Events (Core Phase)</title>
          <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the double-blind Core phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
          <population>Safety set: All patients who received at least one dose of study treatment and had at least one post-baseline safety assessment</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2263"/>
                <count group_id="O2" value="2285"/>
                <count group_id="O3" value="2170"/>
                <count group_id="O4" value="3348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients with at least one AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1987"/>
                    <measurement group_id="O2" value="1970"/>
                    <measurement group_id="O3" value="1872"/>
                    <measurement group_id="O4" value="2915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs suspected to be related tostudy drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="355"/>
                    <measurement group_id="O2" value="350"/>
                    <measurement group_id="O3" value="267"/>
                    <measurement group_id="O4" value="474"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with at least one SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="836"/>
                    <measurement group_id="O2" value="812"/>
                    <measurement group_id="O3" value="741"/>
                    <measurement group_id="O4" value="1204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinued due to SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135"/>
                    <measurement group_id="O2" value="130"/>
                    <measurement group_id="O3" value="117"/>
                    <measurement group_id="O4" value="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinued due to non-seriousAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs leading to study treatmentinterruption</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="268"/>
                    <measurement group_id="O2" value="270"/>
                    <measurement group_id="O3" value="228"/>
                    <measurement group_id="O4" value="399"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summary of Adverse Events (Extension Phase)</title>
        <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the Extension phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
        <time_frame>From start of Extension phase, to end of treatment plus 30 days, up to approximately 2 years</time_frame>
        <population>Extension Safety set: All patients who received at least one dose of study treatment during the Core Phase and who entered the Extension phase.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Summary of Adverse Events (Extension Phase)</title>
          <description>Summary of Adverse Events (AEs) and Serious Adverse Events (SAEs) occurring during the Extension phase of the study. AEs/SAEs are any signs or symptoms that occur during the study treatment.</description>
          <population>Extension Safety set: All patients who received at least one dose of study treatment during the Core Phase and who entered the Extension phase.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1267"/>
                <count group_id="O2" value="1287"/>
                <count group_id="O3" value="1279"/>
                <count group_id="O4" value="1944"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients with at least one AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="788"/>
                    <measurement group_id="O2" value="845"/>
                    <measurement group_id="O3" value="793"/>
                    <measurement group_id="O4" value="1250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs suspected to be related tostudy drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with at least one SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="310"/>
                    <measurement group_id="O2" value="326"/>
                    <measurement group_id="O3" value="322"/>
                    <measurement group_id="O4" value="465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinued due to SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="71"/>
                    <measurement group_id="O3" value="71"/>
                    <measurement group_id="O4" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinued due to non-seriousAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs leading to study treatmentinterruption</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="62"/>
                    <measurement group_id="O4" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 1 (Core Phase): Change From Baseline of the Total Vessel Wall Area at Month 3 in the Bifurcation Region of the Index Carotid Artery</title>
        <time_frame>3 months</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 1 (Core Phase): Change From Baseline of the Total Vessel Wall Area at Month 3 in the Bifurcation Region of the Index Carotid Artery</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 1 (Core Phase): Mean Total Vessel Wall Area Across the Left and Right Carotid Artery at Month 3 and Month 24</title>
        <time_frame>24 months</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 1 (Core Phase): Mean Total Vessel Wall Area Across the Left and Right Carotid Artery at Month 3 and Month 24</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 1 (Core Phase): Change From Baseline in Corresponding Total Vessel Wall Area in the Left and Right Carotid Arteries</title>
        <time_frame>24 months</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 1 (Core Phase): Change From Baseline in Corresponding Total Vessel Wall Area in the Left and Right Carotid Arteries</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 1 (Core Phase): The Existence of a Baseline Total Vessel Wall Area by Treatment Interaction as Well as the Consistency of the Treatment Effect Across Subgroups</title>
        <time_frame>24 months</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 1 (Core Phase): The Existence of a Baseline Total Vessel Wall Area by Treatment Interaction as Well as the Consistency of the Treatment Effect Across Subgroups</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 2 (Core Phase): Change From Baseline in Insulin Sensitivity Index</title>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 2 (Core Phase): Change From Baseline in Insulin Sensitivity Index</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under Curve (AUC) 0-120 Min of Glucose Concentration, Insulin Concentration, Pro-insulin Concentration, and Insulin Concentration/Glucose Concentration Ratio</title>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under Curve (AUC) 0-120 Min of Glucose Concentration, Insulin Concentration, Pro-insulin Concentration, and Insulin Concentration/Glucose Concentration Ratio</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 2 (Core Phase): Change From Baseline in Fasting Pro-Insulin Concentration/Insulin Concentration Ratio</title>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 2 (Core Phase): Change From Baseline in Fasting Pro-Insulin Concentration/Insulin Concentration Ratio</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under the Curve (AUC) 0-120 Min of C-peptide Concentration</title>
        <time_frame>From randomization up to approximately 6 years</time_frame>
        <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
        <group_list>
          <group group_id="O1">
            <title>Group I</title>
            <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O2">
            <title>Group II</title>
            <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O3">
            <title>Group III</title>
            <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
          <group group_id="O4">
            <title>Group IV</title>
            <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Substudy 2 (Core Phase): Change From Baseline in OGTT Stimulated Area Under the Curve (AUC) 0-120 Min of C-peptide Concentration</title>
          <population>Data from subjects were not collected as the substudy was terminated prior to data collection.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Core phase: From randomization to end of treatment plus 30 days; up to approximately 6 years; Extension phase: From start of Extension phase, to end of treatment plus 30 days, up to approximately 2 years.</time_frame>
      <desc>AEs/SAEs are any signs or symptoms that occur during the study treatment. Groups I to IV show AE/SAEs during the Core phase; Group V shows AE/SAEs during the Extension phase. During the Core phase, CV events being study endpoints were exempt from AE/SAE reporting; in contrast, during the Extension phase, all CV events were reported as AEs/SAEs.</desc>
      <group_list>
        <group group_id="E1">
          <title>Group I</title>
          <description>Core phase: Blinded Canakinumab 300 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="E2">
          <title>Group II</title>
          <description>Core phase: Blinded Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="E3">
          <title>Group III</title>
          <description>Core phase: Blinded Canakinumab 50 mg quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="E4">
          <title>Group IV</title>
          <description>Core phase: Blinded matching placebo quarterly subcutaneous + standard of care (SoC) therapy Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy</description>
        </group>
        <group group_id="E5">
          <title>Group V</title>
          <description>Extension phase: Switched to open-label Canakinumab 150 mg quarterly subcutaneous + standard of care (SoC) therapy.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (21.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="239" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="240" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="228" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="378" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="211" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="759" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="743" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="686" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1099" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1216" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal clotting factor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone marrow oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hilar lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Histiocytosis haematophagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Monoclonal B-cell lymphocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="71" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="76" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="66" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="63" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="56" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arteriospasm coronary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="49" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="43" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="30" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="27" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Microvascular coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="42" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Right ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Trifascicular block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Branchial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebrovascular arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hereditary haemochromatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nonketotic hyperglycinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyloric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tracheo-oesophageal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Cerumen impaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Otosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Presbyacusis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism primary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypopituitarism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Primary hyperaldosteronism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Toxic goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blindness transient</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blindness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cataract diabetic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Corneal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Corneal infiltrates</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Macular fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Macular hole</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neovascular age-related macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ocular ischaemic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Papilloedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retinal artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retinal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal skin tags</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anorectal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Appendiceal mucocoele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Appendix disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Change of bowel habit</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colitis microscopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colonic fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic gastroenteropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dieulafoy's vascular malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Duodenal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallstone ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal erosion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal vascular malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic necrotic pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhoids thrombosed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ileal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inguinal hernia strangulated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Large intestinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mesenteric artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mesenteric vascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mouth cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Narcotic bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic duct dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic pseudocyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumatosis intestinalis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ranula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Salivary gland calculus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestine ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombosis mesenteric vessel</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Complication associated with device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Drug intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Heteroplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Implant site irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incarcerated hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="39" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="75" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pacemaker syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pseudocyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Surgical failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular stent restenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Autoimmune hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Biliary cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Biliary dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Biliary fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallbladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic hepatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatosplenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hydrocholecystis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-alcoholic fatty liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Contrast media allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Abscess soft tissue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bacterial disease carrier</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bacterial pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bacteroides infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bartholin's abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Beta haemolytic streptococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bursitis infective staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Campylobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Candida infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cellulitis gangrenous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cellulitis of male external genital organ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Central nervous system infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chikungunya virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholangitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chorioretinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colonic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Corona virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Creutzfeldt-Jakob disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Enteritis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epiglottitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>External ear cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallbladder abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroenteritis clostridial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemophilus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemophilus sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic amoebiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Herpes ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Human ehrlichiosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypopyon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Implant site abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incision site cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infected bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infected cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Infective spondylitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Joint abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Leptospirosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Medical device site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meningitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meningococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mesenteric abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metapneumovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mycobacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mycobacterium avium complex infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteomyelitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteomyelitis blastomyces</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Parametritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Perichondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Periorbital cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peritoneal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="67" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="60" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="83" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="70" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia escherichia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia necrotising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Proctitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Propionibacterium infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pseudomonal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pseudomonas bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyoderma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rubella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Scrub typhus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Septic embolus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Septic necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinusitis fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Staphylococcal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Staphylococcal mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subdiaphragmatic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subdural empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Testicular abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tetanus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection enterococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection fungal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Viral cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Viral diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arterial injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Asbestosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cardiac function disturbance postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Central cord syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Closed globe injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Comminuted fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dural tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Foreign body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fracture displacement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallbladder injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incision site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Incisional hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intentional product misuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Musculoskeletal foreign body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Periprosthetic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Perirenal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumoconiosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Postoperative hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Procedural intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Radiation mucositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal column injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal cord injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal cord injury cervical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tracheal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Traumatic amputation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Traumatic arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Traumatic haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular graft complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm ruptured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase MB increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Body mass index decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Central venous pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clostridium test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Human metapneumovirus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Imaging procedure abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>International normalised ratio decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>N-terminal prohormone brain natriuretic peptide increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Quality of life decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Scan myocardial perfusion abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Troponin T increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Volume blood decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetes with hyperosmolarity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic metabolic decompensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperammonaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperchloraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic hyperosmolar nonketotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypermagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Insulin resistant diabetes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Insulin-requiring type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthritis reactive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chondromalacia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dactylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Finger deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gouty tophus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Immunoglobulin G4 related disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc displacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Jaw cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Joint instability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meniscal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metatarsalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscle swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myofascial pain syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="51" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="26" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Shoulder deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Soft tissue mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Trigger finger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vertebral wedging</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Abdominal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenoma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adenosquamous cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angiolipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angiosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="30" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign cardiac neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign gastric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of scrotum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign small intestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign urinary tract neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bone cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brenner tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the gastrointestinal tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colorectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ductal adenocarcinoma of pancreas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endometrial cancer stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Extranodal marginal zone B-cell lymphoma (MALT type)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Fibrous histiocytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gallbladder adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypergammaglobulinaemia benign monoclonal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Inflammatory pseudotumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Large intestine benign neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Laryngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lentigo maligna</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lip squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="25" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphoproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant fibrous histiocytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant mediastinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of pleura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of unknown primary site</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant peritoneal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mantle cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Medullary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to adrenals</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to pelvis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to pleura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to rectum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastatic bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Monoclonal gammopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mucinous adenocarcinoma of appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mycosis fungoides</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Myelofibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nasal cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neuroendocrine breast tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma refractory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oligodendroglioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oropharyngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ovarian neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Papillary cystadenoma lymphomatosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Papillary renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Penile cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pleomorphic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polycythaemia vera</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal oncocytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rosai-Dorfman syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestine adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the hypopharynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Superficial spreading melanoma stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Testis cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thyroid cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tonsil cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma urethra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tumour perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Apraxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carotid arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carotid artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebellar stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dementia with Lewy bodies</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dystonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Focal dyscognitive seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>IIIrd nerve paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lacunar stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lumbosacral radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mixed dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Optic neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Orthostatic intolerance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral nerve lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Post stroke seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spinal cord infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spondylitic myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stupor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subdural hygroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="25" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thalamic infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombotic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tonic convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Upper motor neurone lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>VIth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device end of service</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device inappropriate shock delivery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device lead issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device loosening</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Device signal detection issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lead dislodgement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alcoholic psychosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anxiety disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bipolar I disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Burnout syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Delirium tremens</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dissociative amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Drug use disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Generalised anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Head banging</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Homicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Psychotic disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Somnambulism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Calculus urethral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Focal segmental glomerulosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis membranous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertensive nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lower urinary tract symptoms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vesicocutaneous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epididymal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Female genital tract fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Genital atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Genital prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatic mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Spermatocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Uterine cervix stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Varicocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Varicose veins pelvic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alveolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Alveolitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchial obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cheyne-Stokes respiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="40" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="33" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dyspnoea paroxysmal nocturnal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypopnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Idiopathic interstitial pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Idiopathic pneumonia syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Laryngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Laryngospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung consolidation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nasal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Nasal turbinate hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pickwickian syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pleural adhesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary alveolar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary microemboli</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory alkalosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Respiratory tract irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vocal cord leukoplakia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brow ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypersensitivity vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Neurodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Prurigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pruritus allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Rhinophyma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Stevens-Johnson syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Homicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aneurysm ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Aortitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arterial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arterial insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Brachiocephalic artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Embolism venous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Femoral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Femoral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Internal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphatic fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Lymphorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Orthostatic hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pallor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Varicose ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Vascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (21.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1271" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="1324" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="1199" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="1905" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="1497" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="142" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="164" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="129" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="228" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="115" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="138" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="146" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="137" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="216" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="110" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="99" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="84" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="169" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="72" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="142" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="143" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="111" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="228" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="68" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="142" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="134" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="173" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="110" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="131" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="162" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="114" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="234" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="160" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="141" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="145" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="118" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="194" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="154" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="153" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="156" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="134" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="252" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="125" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="126" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="129" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="93" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="175" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="123" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="264" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="297" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="263" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="388" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="165" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="181" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="144" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="252" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="184" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="169" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="177" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="157" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="277" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="163" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="145" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="145" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="98" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="204" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="128" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="114" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="126" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="132" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="189" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="107" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="133" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="111" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="120" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="178" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="72" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="151" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="152" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="121" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="233" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="103" subjects_at_risk="5777"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="126" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="123" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="110" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="193" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="112" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="198" subjects_at_risk="2263"/>
                <counts group_id="E2" subjects_affected="216" subjects_at_risk="2285"/>
                <counts group_id="E3" subjects_affected="208" subjects_at_risk="2170"/>
                <counts group_id="E4" subjects_affected="309" subjects_at_risk="3348"/>
                <counts group_id="E5" subjects_affected="241" subjects_at_risk="5777"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Comparison across groups is no longer feasible in the Extension phase because all patients received canakinumab 150 mg. Beyond the primary endpoint, all p-values for the canakinumab 50 mg and 300 mg groups are to be considered nominal only.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Novartis Pharmaceuticals</organization>
      <phone>862-778-8300</phone>
      <email>Novartis.email@novartis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

